HighVista Strategies »

Doordash shares owned by HighVista Strategies

Quarter-by-quarter ownership of Doordash (DASH) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Doordash

Tip: Access up to 7 years of quarterly data

All positions including Doordash held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Doordash by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.0M 6.7k 150.15

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Abivax Sa Sponsored Ads (ABVX)
Praxis Precision Medicines I Com New (PRAX)
Cogent Biosciences (COGT)
Spyre Therapeutics Com New (SYRE)
Vaxcyte (PCVX)
Revolution Medicines (RVMD)
Terns Pharmaceuticals (TERN)
Structure Therapeutics Sponsored Ads (GPCR)
Nuvalent Inc-a (NUVL)
Immunovant (IMVT)
Soleno Therapeutics (SLNO)
Tyra Biosciences (TYRA)
Amylyx Pharmaceuticals (AMLX)
Amazon (AMZN)

View all positions for HighVista Strategies

Top funds holding Doordash

Vanguard Group
Sc Us
BlackRock
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Morgan Stanley
Geode Capital Management
Capital World Investors
Henderson Group
Baillie Gifford & Co
Newlands Management Operations
Wellington Management Company
Capital Research Global Investors
Susquehanna International

View all funds holding Doordash